Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer

BACKGROUND: Recurrent or metastatic cervical cancer represents an aggressive malignancy with a high rate of locoregional and distant failure. Therefore, we evaluated the three-drug combination of paclitaxel–ifosfamide–cisplatin (TIP). METHODS: Systemic chemotherapy-naive patients with advanced metas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosmas, C, Mylonakis, N, Tsakonas, G, Vorgias, G, Karvounis, N, Tsavaris, N, Daladimos, T, Kalinoglou, N, Malamos, N, Akrivos, T, Karabelis, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768083/
https://www.ncbi.nlm.nih.gov/pubmed/19738606
http://dx.doi.org/10.1038/sj.bjc.6605305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768083/
https://www.ncbi.nlm.nih.gov/pubmed/19738606
http://dx.doi.org/10.1038/sj.bjc.6605305

Ejemplares similares